Download PDF
Psychother Psychosom Med Psychol 2018; 68(05): 185-194
DOI: 10.1055/s-0044-100404
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Immunsuppressiva-Adhärenz nach Transplantation

Adherence to Immunosuppressive Medication Following Organ Transplantation
Mariel Nöhre
1   Klinik für Psychosomatik und Psychotherapie, Medizinische Hochschule Hannover
,
Yesim Erim
2   Psychosomatische und Psychotherpeutische Abteilung, Universitätsklinikum Erlangen
,
Frank Vitinius
3   Klinik und Poliklinik für Psychosomatik und Psychotherapie, Universitätsklinikum Köln
,
Felix Klewitz
1   Klinik für Psychosomatik und Psychotherapie, Medizinische Hochschule Hannover
,
Mario Schiffer
4   Klinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover
,
Martina de Zwaan
1   Klinik für Psychosomatik und Psychotherapie, Medizinische Hochschule Hannover
› Author Affiliations
Further Information

Publication History

eingereicht 29 September 2017

akzeptiert 22 December 2017

Publication Date:
13 February 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Transplantation stellt für viele Patienten mit chronischem Organversagen die bestmögliche und teilweise einzige Therapieoption dar. Häufig erleben die Patienten nach erfolgreicher Transplantation eine deutliche Verbesserung ihres Zustandes, allerdings sind sie nicht geheilt sondern noch immer chronisch krank. Das Leben mit dem transplantierten Organ erfordert die konsequente Einnahme immunsuppressiver Medikation, regelmäßige Arztbesuche und die Befolgung von Empfehlungen zur Infektionsvermeidung. Diese Faktoren sind wichtig für ein langes Transplantatüberleben. Besonders die Non-Adhärenz zur immunsuppressiven Medikation ist ein Risikofaktor für Abstoßung des Transplantats. Die Gründe für non-adhärente Verhaltensweisen sind vielfältig. Allerdings ist es von großer Bedeutung die individuellen Gründe genau zu identifizieren, um ihnen angemessen begegnen zu können. Ziel dieses Artikels ist es, einen Überblick über Adhärenz beeinflussende Faktoren zu geben, Möglichkeiten zur Adhärenzerfassung vorzustellen, sowie verschiedene Ansätze zu präsentieren, um die Adhärenz zu verbessern. Randomisiert-kontrollierte Interventionsstudien werden vorgestellt und davon ausgehend Empfehlungen für die Praxis abgeleitet.

Abstract

Organ transplantation is the best and to some extent only option for many patients with chronic organ failure. Usually after successful transplantation patients experience a significant improvement of their condition. Nevertheless, they are not cured but still chronically ill. Living with an organ transplant requires consequent immunosuppression intake, regular physician visits and following the recommendations regarding infection prevention. These factors are important to secure a long transplant survival. Especially non-adherence to immunosuppressants is known as a risk factor for transplant rejection. There are several reasons for non-adherent behavior. However identifying the individual motivations is crucial for addressing them correctly. The aim of this article is to give an overview of factors influencing adherence, to introduce options to assess adherence and to present ways to improve adherence. Randomized-controlled intervention studies are presented and on that basis recommendations for clinical practice are derived.

Schlüsselwörter

Adhärenz - Organtransplantation - Immunsuppression - Interventionen

Key words

adherence - organ transplantation - immunosuppression - interventions

Ergänzendes Material

 

  • Literatur

  • 1 Deutsche Stiftung Organtransplantation. Zahlen zur Organspende und -transplantation in Deutschland 2016 (15.01.2017). Im Internet: https://www.dso.de/servicecenter/krankenhaeuser/zahlen-zurorganspende-und-transplantation.html ; Stand: 04.12.2017
    PubMed
  • 2 Erim Y, Beckmann M, Klein C. et al. Psychosomatische Aspekte der Transplantationsmedizin. Psychother Psych Med 2013; 63: 238-249
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Pabst S, Bertram A, Zimmermann T. et al. Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates. J Psychosom Res 2015; 79: 364-371
    CrossrefPubMedGoogle Scholar
  • 4 World Health Organization. Adherence to long-term therapies: evidence for action (01.01.2003) Im Internet: http://www.who.int/chp/knowledge/publications/adherence_report/en/ ; Stand: 12.08.2017
    PubMed
  • 5 Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567
    CrossrefPubMedGoogle Scholar
  • 6 Germani G, Lazzaro S, Gnoato F. et al Nonadherent behaviors after solid organ transplantation. Transplant Proc 2011; 43: 318-323
    CrossrefPubMedGoogle Scholar
  • 7 De Bleser L, Dobbels F, Berben L. et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int 2011; 24: 882-891
    CrossrefPubMedGoogle Scholar
  • 8 Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management. Transplant Rev 2015; 29: 78-84
    CrossrefPubMedGoogle Scholar
  • 9 Borra LC, Roodnat JI, Kal JA. et al. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. Nephrol Dial Transplant 2010; 25: 2757-2763
    CrossrefPubMedGoogle Scholar
  • 10 Rodrigo E, Segundo DS, Fernandez-Fresnedo G. et al. Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development. Transplantation 2016; 100: 2479-2485
    CrossrefPubMedGoogle Scholar
  • 11 Sellarés J, de Freitas DG, Mengel M. et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399
    PubMedGoogle Scholar
  • 12 Saint-Marcoux F, Woillard JB, Monchaud C. et al. How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation. Pharmacol Res 2015; 100: 281-287
    CrossrefPubMedGoogle Scholar
  • 13 Pinsky BW, Takemoto SK, Lentine KL. et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009; 9: 2597-2606
    CrossrefPubMedGoogle Scholar
  • 14 Dobbels F, Berben L, De Geest S. et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: A systematic review. Transplantation 2010; 90: 205-219
    PubMedGoogle Scholar
  • 15 Goetzmann L, Klaghofer R, Spindler A. et al. Die „Medikamenten-Erfahrungs-Skala für Immunsuppressiva” (MESI) - Erste Ergebnisse zu einem neuen Screeninginstrument in der Transplantationsmedizin. Psychother Psych Med 2006; 56: 49-55
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Klaghofer R, Sarac N, Schwegler K. et al. Fragebogen zur psychischen Verarbeitung einer Organtransplantation: Deutsche Validierung des Transplant Effects Questionnaire (TxEQ). Z Psychosom Med Psychother 2008; 54: 174-188
    PubMedGoogle Scholar
  • 17 Chisholm MA, Lance CE, Williamson GM. et al. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplant 2005; 20: 181-188
    CrossrefPubMedGoogle Scholar
  • 18 Schmid-Mohler G, Thut MP, Wüthrich RP. et al. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant 2010; 24: 213-222
    CrossrefPubMedGoogle Scholar
  • 19 Scheel J, Reber S, Stoessel L. et al. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation. BMC Nephrol DOI: 10.1186/s12882-017-0517-6.
    CrossrefPubMedGoogle Scholar
  • 20 Schäfer-Keller P, Steiger J, Bock A. et al. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616-626
    CrossrefPubMedGoogle Scholar
  • 21 Pollock-Barziv SM, Finkelstein Y, Manlhiot C. et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 2010; 14: 968-975
    CrossrefPubMedGoogle Scholar
  • 22 Burckart GJ, Liu XI. Pharmacogenetics in transplant patients: Can it predict pharmacokinetics and pharmacodynamics?. Ther Drug Monit 2006; 28: 23-30
    CrossrefPubMedGoogle Scholar
  • 23 Denhaerynck K, Schäfer-Keller P, Young J. et al. Examining assumptions regarding valid electronic monitoring of medication therapy: Development of a validation framework and its application on a european sample of kidney transplant patients. BMC Med Res Methodol DOI: 10.1186/1471-2288-8-5.
    CrossrefPubMedGoogle Scholar
  • 24 Panyi N, Erim Y. Manualisierte Psychotherapie zur Optimierung der Immunsuppressiva-Adhärenz bei Patienten nach Nierentransplantation: Ergebnisse einer Machbarkeitsstudie. Z Psychosom Med Psychother 2017; 63: 189-201
    PubMedGoogle Scholar
  • 25 Prendergast MB, Gaston RS. Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol 2010; 5: 1305-1311
    CrossrefPubMedGoogle Scholar
  • 26 Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplantation 1998; 66: 1718-1726
    CrossrefPubMedGoogle Scholar
  • 27 Richter A, Anton SF, Koch P. et al. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307-2335
    CrossrefPubMedGoogle Scholar
  • 28 Cassuto E, Pageaux GP, Cantarovich D. et al. Adherence to and acceptance of once-daily tacrolimus after kidney and liver transplant: Results from OSIRIS, a french observational study. Transplantation 2016; 100: 2099-2106
    CrossrefPubMedGoogle Scholar
  • 29 Doesch AO, Mueller S, Akyol C. et al. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug Des Devel Ther 2013; 7: 1253-1258
    PubMedGoogle Scholar
  • 30 Denhaerynck K, Steiger J, Bock A. et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007; 7: 108-116
    CrossrefPubMedGoogle Scholar
  • 31 Steinert A, Weddige J. Therapietreue: Unterstützung per Smartphone-App. Dtsch Arztebl 2015; 112 (Suppl. 10) 4-5
    PubMedGoogle Scholar
  • 32 Weng FL, Chandwani S, Kurtyka KM. et al. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: A cross-sectional study. BMC Nephrol DOI: 10.1186/1471-2369-14-261.
    CrossrefPubMedGoogle Scholar
  • 33 Demian MN, Shapiro RJ, Thornton WL. An observational study of health literacy and medication adherence in adult kidney transplant recipients. Clin Kidney J 2016; 9: 858-865
    CrossrefPubMedGoogle Scholar
  • 34 Bertram A, Pabst S, Zimmermann T. et al. How can you be adherent if you don't know how?. Transpl Int 2016; 29: 830-832
    CrossrefPubMedGoogle Scholar
  • 35 Dageforde LA, Petersen AW, Feurer ID. et al. Health literacy of living kidney donors and kidney transplant recipients. Transplantation 2014; 98: 88-93
    PubMedGoogle Scholar
  • 36 Lennerling A, Forsberg A. Self-reported non-adherence and beliefs about medication in a swedish kidney transplant population. Open Nurs J 2012; 6: 41-46
    CrossrefPubMedGoogle Scholar
  • 37 Hugon A, Roustit M, Lehmann A. et al. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Transplantation 2014; 98: 222-228
    PubMedGoogle Scholar
  • 38 Foot H, La Caze A, Gujral G. et al. The necessity-concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient Educ Couns 2016; 99: 706-717
    CrossrefPubMedGoogle Scholar
  • 39 Prüfe J, Dierks ML, Bethe D. et al. Transition structures and timing of transfer from paediatric to adult-based care after kidney transplantation in Germany: A qualitative study. BMJ Open DOI: 10.1136/bmjopen-2016-015593.
    CrossrefPubMedGoogle Scholar
  • 40 Kreuzer M, Prüfe J, Bethe D. et al. The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: Study protocol for a randomized controlled trial. Trials DOI: 10.1186/1745-6215-15-505.
    CrossrefPubMedGoogle Scholar
  • 41 Ladin K, Daniels A, Osani M. et al. Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando) 2017; 32: 16-28
    PubMedGoogle Scholar
  • 42 Denhaerynck K, Dobbels F, Cleemput I. et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 2005; 18: 1121-1133
    CrossrefPubMedGoogle Scholar
  • 43 Zimmermann T, Pabst S, Bertram A. et al. Differences in emotional responses in living and deceased donor kidney transplant patients. Clin Kidney J 2016; 9: 503-509
    CrossrefPubMedGoogle Scholar
  • 44 Dew MA, Rosenberger EM, Myaskovsky L. et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: A systematic review and meta-analysis. Transplantation 2015; 100: 988-1003
    CrossrefPubMedGoogle Scholar
  • 45 Belaiche S, Decaudin B, Dharancy S. et al. Factors relevant to medication non-adherence in kidney transplant: A systematic review. Int J. Clin Pharm 2017; 39: 582-593
    PubMedGoogle Scholar
  • 46 Davydow DS, Lease ED, Reyes JD. Posttraumatic stress disorder in organ transplant recipients: A systematic review. Gen Hosp Psychiatry 2015; 37: 387-398
    CrossrefPubMedGoogle Scholar
  • 47 Chisholm MA, Williamson GM, Lance CE. et al. Predicting adherence to immunosuppressant therapy: A prospective analysis of the theory of planned behaviour. Nephrol Dial Transplant 2007; 22: 2339-2348
    CrossrefPubMedGoogle Scholar
  • 48 De Bleser L, Matteson M, Dobbels F. et al. Interventions to improve medication-adherence after transplantation: A systematic review. Transpl Int 2009; 22: 780-797
    CrossrefPubMedGoogle Scholar
  • 49 Low JK, Williams A, Manias E. et al. Interventions to improve medication adherence in adult kidney transplant recipients: A systematic review. Nephrol Dial Transplant 2015; 30: 752-761
    CrossrefPubMedGoogle Scholar
  • 50 Zhu Y, Zhou Y, Zhang L. et al. Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: A meta-analysis and systematic review. J Investig Med 2017; 65: 1049-1056
    CrossrefPubMedGoogle Scholar
  • 51 Reese PP, Bloom RD, Trofe-Clark J. et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: A randomized trial. Am J Kidney Dis 2017; 69: 400-409
    CrossrefPubMedGoogle Scholar
  • 52 Klein A, Otto G, Kramer I. Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: A prospective, randomized, controlled trial using electronic monitoring. Transplantation 2009; 87: 839-847
    CrossrefPubMedGoogle Scholar
  • 53 Dobbels F, De Bleser L, Berben L. et al. Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx Trial. J Heart Lung Transplant 2017; 36: 499-508
    CrossrefPubMedGoogle Scholar
  • 54 Hardstaff R, Green K, Talbot D. Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplant Proc 2003; 35: 796-797
    CrossrefPubMedGoogle Scholar
  • 55 Cukor D, Ver Halen N, Pencille M. et al. A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron 2017; 135: 6-14
    CrossrefPubMedGoogle Scholar
  • 56 Russell C, Conn V, Ashbaugh C. et al. Taking immunosuppressive medications effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients. Clin Transplant 2011; 25: 864-870
    CrossrefPubMedGoogle Scholar
  • 57 Nevins TE, Kruse L, Skeans MA. et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565-1570
    CrossrefPubMedGoogle Scholar
  • 58 McGillicuddy JW, Gregoski MJ, Weiland AK. et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: A proof-of-concept randomized controlled trial. JMIR Res Protoc DOI: 10.2196/resprot.2633.
    CrossrefPubMedGoogle Scholar
  • 59 Bessa AB, Felipe CR, Hannun P. et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Ther Drug Monit 2016; 38: 447-455
    PubMedGoogle Scholar
  • 60 Chisholm MA, Mulloy LL, Jagadeesan M. et al. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transplant 2001; 15: 330-336
    CrossrefPubMedGoogle Scholar
  • 61 De Geest S, Schafer-Keller P, Denhaerynck K. et al. Supporting medication adherence in renal transplantation (SMART): A pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006; 20: 359-368
    CrossrefPubMedGoogle Scholar
  • 62 Garcia MF, Bravin AM, Garcia PD. et al. Behavioral measures to reduce non-adherence in renal transplant recipients: A prospective randomized controlled trial. Int Urol Nephrol. 2015; 47: 1899-1905
    CrossrefPubMedGoogle Scholar
  • 63 Chisholm-Burns MA, Spivey CA, Graff Zivin J. et al. Improving outcomes of renal transplant recipients with behavioral adherence contracts: A randomized controlled trial. Am J Transplant 2013; 13: 2364-2373
    CrossrefPubMedGoogle Scholar
  • 64 Pape L, de Zwaan M, Tegtbur U. et al The KTx360 Degrees -study: A multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults. BMC Health Serv Res DOI: 10.1186/s12913-017-2545-0.
    CrossrefPubMedGoogle Scholar
  • 65 Chisholm-Burns MA, Spivey CA, Sredzinski E. et al. Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. J Am Pharm Assoc 2012; 52: 816-822
    CrossrefPubMedGoogle Scholar